Literature DB >> 12545084

Hormonal contraceptive use and HIV-1 infection in a population-based cohort in Rakai, Uganda.

Mohammed Kiddugavu1, Fred Makumbi, Maria J Wawer, David Serwadda, Nelson K Sewankambo, Fred Wabwire-Mangen, Tom Lutalo, Mary Meehan, Ronald H Gray.   

Abstract

BACKGROUND: Hormonal contraceptives have been associated with increased risk of HIV acquisition.
METHODS: The association between hormonal contraception use and HIV acquisition was assessed in a rural community-based cohort in Rakai District, Uganda. A group of 5117 sexually active HIV-negative women were surveyed at 10 month intervals between 1994 and 1999. Information on demographic and sociobehavioral characteristics, use of hormonal contraception (pill and injectable methods), condoms and the number of sexual partners was obtained by home-based interview. HIV incidence rate ratios (IRR) and 95% confidence intervals (CI) associated with hormonal contraception were estimated by multivariate Poisson regression after adjustment for age, condom use, number of sexual partners, marital status, education and history of genital ulcer disease.
RESULTS: At one or more interviews, 16.6% of women reported use of hormonal contraceptives and 23.0% reported condom use. HIV incidence was 2.3/100 person-years in hormonal contraceptive users compared with 1.5/100 person-years in non-hormonal contraceptive users (unadjusted IRR, 1.56; 95% CI, 1.00-2.33). After multivariate adjustment, the IRR associated with hormonal contraceptives was reduced to 0.94 (95% CI, 0.53-1.64). The adjusted IRR was 1.12 (95% CI, 0.48-2.56) with oral contraceptive use and 0.84 (95%CI, 0.41-1.72) with injectable methods.
CONCLUSION: Use of hormonal contraception is not associated with HIV acquisition after adjustment for behavioral confounding.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12545084     DOI: 10.1097/00002030-200301240-00014

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  31 in total

Review 1.  Impact of measurement error in the study of sexually transmitted infections.

Authors:  L Myer; C Morroni; B G Link
Journal:  Sex Transm Infect       Date:  2004-08       Impact factor: 3.519

2.  Maximizing the impact of HIV prevention efforts: interventions for couples.

Authors:  Amy Medley; Rachel Baggaley; Pamela Bachanas; Myron Cohen; Nathan Shaffer; Ying-Ru Lo
Journal:  AIDS Care       Date:  2013-05-08

3.  Plasma concentration of injectable contraceptive correlates with reduced cervicovaginal growth factor expression in South African women.

Authors:  Refilwe P Molatlhegi; Lenine J Liebenberg; Alasdair Leslie; Laura Noel-Romas; Amanda Mabhula; Nobuhle Mchunu; Michelle Perner; Kenzie Birse; Sinaye Ngcapu; John H Adamson; Katya Govender; Nigel J Garrett; Natasha Samsunder; Adam D Burgener; Salim S Abdool Karim; Quarraisha Abdool Karim; Jo-Ann S Passmore; Lyle R McKinnon
Journal:  Mucosal Immunol       Date:  2020-01-02       Impact factor: 7.313

4.  Barriers of Mucosal Entry of HIV/SIV.

Authors:  Ann M Carias; Thomas J Hope
Journal:  Curr Immunol Rev       Date:  2019

5.  Depo-Provera does not alter disease progression in SIVmac-infected female Chinese rhesus macaques.

Authors:  Brigitte Sanders-Beer; Tahar Babas; Keith Mansfield; Dawn Golightly; Joshua Kramer; Abigail Bowlsbey; Debora Sites; Lourdes Nieves-Duran; Shuling Lin; Sherry Rippeon; Ginger Donnelly; Lowrey Rhodes; Yvette Edghill Spano
Journal:  AIDS Res Hum Retroviruses       Date:  2010-04       Impact factor: 2.205

6.  Hormonal contraception and HIV acquisition: reanalysis using marginal structural modeling.

Authors:  Charles S Morrison; Pai-Lien Chen; Cynthia Kwok; Barbra A Richardson; Tsungai Chipato; Roy Mugerwa; Josaphat Byamugisha; Nancy Padian; David D Celentano; Robert A Salata
Journal:  AIDS       Date:  2010-07-17       Impact factor: 4.177

Review 7.  Contraceptive methods and risk of HIV acquisition or female-to-male transmission.

Authors:  Lisa B Haddad; Chelsea B Polis; Anandi N Sheth; Jennifer Brown; Athena P Kourtis; Caroline King; Rana Chakraborty; Igho Ofotokun
Journal:  Curr HIV/AIDS Rep       Date:  2014-12       Impact factor: 5.071

Review 8.  A critique of international indicators of sexual risk behaviour.

Authors:  E Slaymaker
Journal:  Sex Transm Infect       Date:  2004-12       Impact factor: 3.519

Review 9.  Sex steroid hormones, hormonal contraception, and the immunobiology of human immunodeficiency virus-1 infection.

Authors:  Zdenek Hel; Elizabeth Stringer; Jiri Mestecky
Journal:  Endocr Rev       Date:  2009-11-10       Impact factor: 19.871

10.  Hormonal contraception and HIV-1 infection: medroxyprogesterone acetate suppresses innate and adaptive immune mechanisms.

Authors:  Richard P H Huijbregts; E Scott Helton; Katherine G Michel; Steffanie Sabbaj; Holly E Richter; Paul A Goepfert; Zdenek Hel
Journal:  Endocrinology       Date:  2013-01-25       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.